1. Epidemiology and Global Health
  2. Microbiology and Infectious Disease
Download icon

Eighteenth century Yersinia pestis genomes reveal the long-term persistence of an historical plague focus

  1. Kirsten I Bos
  2. Alexander Herbig
  3. Jason Sahl
  4. Nicholas Waglechner
  5. Mathieu Fourment
  6. Stephen A Forrest
  7. Jennifer Klunk
  8. Verena J Schuenemann
  9. Debi Poinar
  10. Melanie Kuch
  11. G Brian Golding
  12. Olivier Dutour
  13. Paul Keim
  14. David M Wagner
  15. Edward C Holmes
  16. Johannes Krause  Is a corresponding author
  17. Hendrik N Poinar
  1. University of Tübingen, Germany
  2. Northern Arizona University, United States
  3. McMaster University, Canada
  4. The University of Sydney, Australia
  5. Université Bordeaux, France
Research Article
  • Cited 77
  • Views 6,818
  • Annotations
Cite this article as: eLife 2016;5:e12994 doi: 10.7554/eLife.12994

Abstract

The 14th-18th century pandemic of Yersinia pestis caused devastating disease outbreaks in Europe for almost 400 years. The reasons for plague's persistence and abrupt disappearance in Europe are poorly understood, but could have been due to either the presence of now-extinct plague foci in Europe itself, or successive disease introductions from other locations. Here we present five Y. pestis genomes from one of the last European outbreaks of plague, from 1722 in Marseille, France. The lineage identified has not been found in any extant Y. pestis foci sampled to date, and has its ancestry in strains obtained from victims of the 14th century Black Death. These data suggest the existence of a previously uncharacterized historical plague focus that persisted for at least three centuries. We propose that this disease source may have been responsible for the many resurgences of plague in Europe following the Black Death.

Article and author information

Author details

  1. Kirsten I Bos

    Department of Archeological Sciences, University of Tübingen, Tübingen, Germany
    Competing interests
    The authors declare that no competing interests exist.

  2. Alexander Herbig

    Department of Archeological Sciences, University of Tübingen, Tübingen, Germany
    Competing interests
    The authors declare that no competing interests exist.

  3. Jason Sahl

    Center for Microbial Genetics and Genomics, Northern Arizona University, Flagstaff, United States
    Competing interests
    The authors declare that no competing interests exist.

  4. Nicholas Waglechner

    Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Canada
    Competing interests
    The authors declare that no competing interests exist.

  5. Mathieu Fourment

    Marie Bashir Institute for Infectious Diseases and Biosecurity, Charles Perkins Centre, School of Life and Environmental Sciences and Sydney Medical School, The University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.

  6. Stephen A Forrest

    Department of Archeological Sciences, University of Tübingen, Tübingen, Germany
    Competing interests
    The authors declare that no competing interests exist.

  7. Jennifer Klunk

    McMaster Ancient DNA Centre, Department of Anthropology, McMaster University, Hamilton, Canada
    Competing interests
    The authors declare that no competing interests exist.

  8. Verena J Schuenemann

    Department of Archeological Sciences, University of Tübingen, Tübingen, Germany
    Competing interests
    The authors declare that no competing interests exist.

  9. Debi Poinar

    McMaster Ancient DNA Centre, Department of Anthropology, McMaster University, Hamilton, Canada
    Competing interests
    The authors declare that no competing interests exist.

  10. Melanie Kuch

    McMaster Ancient DNA Centre, Department of Anthropology, McMaster University, Hamilton, Canada
    Competing interests
    The authors declare that no competing interests exist.

  11. G Brian Golding

    Department of Biology, McMaster University, Hamilton, Canada
    Competing interests
    The authors declare that no competing interests exist.

  12. Olivier Dutour

    Laboratoire d'anthropologie biologique Paul Broca, Ecole Pratique des Hautes Etudes, PACEA, Université Bordeaux, Bordeaux, France
    Competing interests
    The authors declare that no competing interests exist.

  13. Paul Keim

    Center for Microbial Genetics and Genomics, Northern Arizona University, Flagstaff, United States
    Competing interests
    The authors declare that no competing interests exist.

  14. David M Wagner

    Center for Microbial Genetics and Genomics, Northern Arizona University, Flagstaff, United States
    Competing interests
    The authors declare that no competing interests exist.

  15. Edward C Holmes

    Marie Bashir Institute for Infectious Diseases and Biosecurity, Charles Perkins Centre, School of Life and Environmental Sciences and Sydney Medical School, The University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.

  16. Johannes Krause

    Department of Archeological Sciences, University of Tübingen, Tübingen, Germany
    For correspondence
    johannes.krause@uni-tuebingen.de
    Competing interests
    The authors declare that no competing interests exist.

  17. Hendrik N Poinar

    Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Canada
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Richard A Neher, Max Planck Institute for Developmental Biology, Germany

Publication history

  1. Received: November 12, 2015
  2. Accepted: January 19, 2016
  3. Accepted Manuscript published: January 21, 2016 (version 1)
  4. Version of Record published: March 11, 2016 (version 2)

Copyright

© 2016, Bos et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,818
    Page views
  • 1,436
    Downloads
  • 77
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Categories and tags

Further reading

  1. Why did plagues stop? Kirsten Bos talk about pathogens from the past

    Podcast

    DNA from 18th century teeth reveals plague secrets.

    1. Epidemiology and Global Health
    2. Medicine

    Effects of an urban sanitation intervention on childhood enteric infection and diarrhea in Maputo, Mozambique: a controlled before-and-after trial

    Jackie Knee et al.
    Research Article

    We conducted a controlled before-and-after trial to evaluate the impact of an onsite urban sanitation intervention on the prevalence of enteric infection, soil transmitted helminth re-infection, and diarrhea among children in Maputo, Mozambique. A non-governmental organization replaced existing poor-quality latrines with pour-flush toilets with septic tanks serving household clusters. We enrolled children aged 1-48 months at baseline and measured outcomes before and 12 and 24 months after the intervention, with concurrent measurement among children in a comparable control arm. Despite nearly exclusive use, we found no evidence that intervention affected the prevalence of any measured outcome after 12 or 24 months of exposure. Among children born into study sites after intervention, we observed a reduced prevalence of Trichuris and Shigella infection relative to the same age group at baseline (<2 years old). Protection from birth may be important to reduce exposure to and infection with enteric pathogens in this setting.

    1. Epidemiology and Global Health
    2. Microbiology and Infectious Disease

    Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection

    Nick K Jones et al.
    Research Advance

    The BNT162b2 mRNA COVID-19 vaccine (Pfizer-BioNTech) is being utilised internationally for mass COVID-19 vaccination. Evidence of single-dose protection against symptomatic disease has encouraged some countries to opt for delayed booster doses of BNT162b2, but the effect of this strategy on rates of asymptomatic SARS-CoV-2 infection remains unknown. We previously demonstrated frequent pauci- and asymptomatic SARS-CoV-2 infection amongst healthcare workers (HCWs) during the UK’s first wave of the COVID-19 pandemic, using a comprehensive PCR-based HCW screening programme (Rivett et al., 2020; Jones et al., 2020). Here, we evaluate the effect of first-dose BNT162b2 vaccination on test positivity rates, and find a four-fold reduction in asymptomatic infection amongst HCWs ≥12 days post-vaccination. These data provide real-world evidence of short-term protection against asymptomatic SARS-CoV-2 infection following a single dose of BNT162b2 vaccine, suggesting that mass first-dose vaccination will reduce SARS-CoV-2 transmission, as well as the burden of COVID-19 disease.